Tag: Chen Yan
Structure Therapeutics raises USD180m in ADS offering
Biopharmaceutical company Structure Therapeutics raised USD134 million in a Nasdaq listing, offering 8.95 million American depositary shares (ADS) priced at USD15 each
KE overcomes hurdles to list back in HK
Chinese property platform KE overcame significant hurdles to complete a dual-primary listing via introduction on the HKEX with weighted voting rights (WVR) in the first such so-called “homecoming” debut in Hong Kong
Rise with the tide
Chen Yan, GC of KE Holdings, shares his experiences in adapting to China’s new personal data law
